The oxidative modification hypothesis of atherogenesis: an overview.

[1]  B. Mazumder,et al.  Ceruloplasmin and cardiovascular disease. , 2000, Free radical biology & medicine.

[2]  H. Jo,et al.  Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. , 2000, Free radical biology & medicine.

[3]  A. Carr,et al.  The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. , 2000, Free radical biology & medicine.

[4]  R. Murphy,et al.  Bioactive phospholipid oxidation products. , 2000, Free radical biology & medicine.

[5]  V. A. Folcik,et al.  Lipoxygenases and atherosclerosis: protection versus pathogenesis. , 2000, Free radical biology & medicine.

[6]  G. FitzGerald,et al.  Indices of lipid peroxidation in vivo: strengths and limitations. , 2000, Free radical biology & medicine.

[7]  G. Silverman,et al.  Immunological responses to oxidized LDL. , 2000, Free radical biology & medicine.

[8]  J. Berliner,et al.  Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. , 2000, Free radical biology & medicine.

[9]  G. Chisolm,et al.  Regulation of cell growth by oxidized LDL. , 2000, Free radical biology & medicine.

[10]  S. Hazen,et al.  Myeloperoxidase-generated oxidants and atherosclerosis. , 2000, Free radical biology & medicine.

[11]  J. Baynes,et al.  Glycoxidation and lipoxidation in atherogenesis. , 2000, Free radical biology & medicine.

[12]  Hazen.  Oxidation and atherosclerosis , 2000, Free radical biology & medicine.

[13]  K. Uchida.  Role of reactive aldehyde in cardiovascular diseases. , 2000, Free radical biology & medicine.

[14]  R. Stocker,et al.  Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. , 2000, Free radical biology & medicine.

[15]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[16]  M. Hofker,et al.  Scavenging new insights into atherogenesis. , 2000, The Journal of clinical investigation.

[17]  S. Hazen,et al.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.

[18]  E. Dennis,et al.  The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein* , 2000, The Journal of Biological Chemistry.

[19]  C. Hennekens,et al.  Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. , 2000, Annals of epidemiology.

[20]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[21]  M. Linton,et al.  Current perspectives on statins. , 2000, Circulation.

[22]  R. Stocker.  Dietary and pharmacological antioxidants in atherosclerosis. , 1999, Current opinion in lipidology.

[23]  D. Albanes,et al.  The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial. , 1999, Atherosclerosis.

[24]  S. Hazen,et al.  The Oxidation of Lipoproteins by Monocytes-Macrophages , 1999, The Journal of Biological Chemistry.

[25]  J. Berliner,et al.  Structural Identification of a Novel Pro-inflammatory Epoxyisoprostane Phospholipid in Mildly Oxidized Low Density Lipoprotein* , 1999, The Journal of Biological Chemistry.

[26]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[27]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[28]  D. Rader,et al.  Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. , 1999, The Journal of clinical investigation.

[29]  T. Kodama,et al.  Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. , 1999, Atherosclerosis.

[30]  D. Steinberg.  At last, direct evidence that lipoxygenases play a role in atherogenesis. , 1999, The Journal of clinical investigation.

[31]  E. Dennis,et al.  Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Dennis,et al.  Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Monier,et al.  Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[34]  B. McManus,et al.  Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. , 1999, Circulation.

[35]  R. Stocker,et al.  Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Andrew J. Brown,et al.  Oxysterols and atherosclerosis. , 1999, Atherosclerosis.

[37]  A. Sevanian,et al.  Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[38]  J. Heinecke.  Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. , 1998, Atherosclerosis.

[39]  D. Rader,et al.  Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice , 1998, Nature Medicine.

[40]  A. Chait,et al.  Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[41]  T. Kodama,et al.  Antiatherogenic effects of the antioxidant BO-653 in three different animal models. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Thyberg,et al.  An animal model to study local oxidation of LDL and its biological effects in the arterial wall. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[43]  D. Steinberg,et al.  Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. , 1998, Journal of lipid research.

[44]  T. Kodama,et al.  Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[45]  D. Steinberg,et al.  Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Virtamo,et al.  Retinal vascular changes following supplementation with alpha-tocopherol or beta-carotene. , 1998, Acta ophthalmologica Scandinavica.

[47]  A. Daugherty,et al.  A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. , 1998, Atherosclerosis.

[48]  T. Kodama,et al.  The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock , 1997, The Journal of experimental medicine.

[49]  S. Feinmark,et al.  Is there a role for 15-lipoxygenase in atherogenesis? , 1997, Biochemical pharmacology.

[50]  J. Heinecke.  Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis , 1997, Current opinion in lipidology.

[51]  J. Witztum,et al.  Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis , 1997, Hepatology.

[52]  R. Dean,et al.  7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. , 1997, Journal of lipid research.

[53]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[54]  J. Keaney,et al.  Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.

[55]  J. Huber,et al.  Oxidized Lipids in Atherogenesis: Formation, Destruction and Action , 1997, Thrombosis and Haemostasis.

[56]  N. Maeda,et al.  Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. , 1997, The Journal of clinical investigation.

[57]  L. Chan,et al.  The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actions. , 1997, Current opinion in lipidology.

[58]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[59]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[60]  F. Ursini,et al.  LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. , 1997, Journal of lipid research.

[61]  D. Steinberg,et al.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.

[62]  J. Cornhill,et al.  Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. , 1996, The Journal of clinical investigation.

[63]  B. Nordestgaard,et al.  Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. , 1996, Circulation.

[64]  J. Hokanson,et al.  Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein. , 1996, Circulation.

[65]  G. Chisolm,et al.  Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. , 1996, Journal of lipid research.

[66]  D. Steinberg.  Oxidized low density lipoprotein--an extreme example of lipoprotein heterogeneity. , 1996, Israel journal of medical sciences.

[67]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[68]  E. Stadtman,et al.  Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. , 1995, Archives of biochemistry and biophysics.

[69]  D. Steinberg,et al.  The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[70]  G. Schonfeld,et al.  Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. , 1995, The Journal of clinical investigation.

[71]  D. Steinberg,et al.  Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[72]  G. Chisolm,et al.  In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. , 1995, The Journal of clinical investigation.

[73]  A. Sevanian,et al.  Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. , 1995, Journal of lipid research.

[74]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[75]  D. Steinberg.  Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? , 1995, The Lancet.

[76]  J. Isner,et al.  Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.

[77]  D. Morel,et al.  7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Witztum,et al.  Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. , 1994, The Journal of clinical investigation.

[79]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[80]  P. Demacker,et al.  Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[81]  T. Carew,et al.  A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. , 1994, The Journal of clinical investigation.

[82]  J. Guyton,et al.  Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[83]  P. Reaven,et al.  Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[84]  E. Sigal,et al.  Oxidation, Lipoxygenase, and Atherogenesis , 1994, Annals of the New York Academy of Sciences.

[85]  D. Kramsch,et al.  Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). , 1994, Journal of lipid research.

[86]  V. Ord,et al.  ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[87]  J. Loscalzo,et al.  Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Qi Chen,et al.  Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[89]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[90]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[91]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[92]  M. Hurme,et al.  Regulation of endothelial adhesion molecules by ligands binding to the scavenger receptor , 1993, Clinical and experimental immunology.

[93]  P. Reaven,et al.  Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[94]  A. Girotti,et al.  Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. , 1993, Journal of lipid research.

[95]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[96]  G. Chisolm.  Cytotoxicity of oxidized lipoproteins , 1991 .

[97]  D. Steinberg.  Antioxidants and atherosclerosis. A current assessment. , 1991, Circulation.

[98]  H. Esterbauer,et al.  Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. , 1991, Journal of lipid research.

[99]  M. Freeman,et al.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[100]  A. Nègre-Salvayre,et al.  Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. , 1990, Biochimica et biophysica acta.

[101]  M. Freeman,et al.  Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II , 1990, Nature.

[102]  M. Freeman,et al.  Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.

[103]  D. Morel,et al.  Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. , 1989, Journal of lipid research.

[104]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[105]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[106]  M. Haberland,et al.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.

[107]  W. Pryor,et al.  Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous SDS [sodium dodecyl sulfate] micelle solutions , 1988 .

[108]  G. Cazzolato,et al.  Presence of a Modified Low Density Lipoprotein in Humans , 1988, Arteriosclerosis.

[109]  K. H. Carpenter,et al.  What is the significance of ceroid in human atherosclerosis? , 1987, Archives of pathology & laboratory medicine.

[110]  G. Chisolm,et al.  Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. , 1987, Chemistry and physics of lipids.

[111]  G. Chisolm,et al.  Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. , 1987, The Journal of biological chemistry.

[112]  D. Steinberg,et al.  Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.

[113]  D. Morel,et al.  Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic , 1985, Journal of leukocyte biology.

[114]  A. Chait,et al.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. , 1984, The Journal of clinical investigation.

[115]  D. Morel,et al.  Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation , 1984, Arteriosclerosis.

[116]  J L Witztum,et al.  Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[117]  D. Morel,et al.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.

[118]  L. J. Lewis,et al.  Lipoprotein Oxidation and Lipoprotein‐lnduced Cytotoxicity , 1983, Arteriosclerosis.

[119]  D. Steinberg,et al.  Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.

[120]  D. Steinberg,et al.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[121]  G. Chisolm,et al.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. , 1979, Atherosclerosis.

[122]  A. J. Lusis,et al.  Pathogenesis of Atherosclerosis , 1964, The American journal of cardiology.

[123]  D. Albanes,et al.  Controlled Trial of α-Tocopherol and β-Carotene Supplements on Stroke Incidence and Mortality in Male Smokers , 2000 .

[124]  E. Rimm,et al.  Antioxidants for vascular disease. , 2000, The Medical clinics of North America.

[125]  W. Pryor.  Vitamin E and heart disease: basic science to clinical intervention trials. , 2000, Free radical biology & medicine.

[126]  D. Conrad.  The arachidonate 12/15 lipoxygenases , 1999, Clinical reviews in allergy & immunology.

[127]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.

[128]  A. Sevanian,et al.  Antioxidants and atherosclerosis: an overview , 1997, BioFactors.

[129]  G. Saidel,et al.  Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. , 1997, Circulation research.

[130]  D. Steinberg,et al.  Role of oxidized LDL and antioxidants in atherosclerosis. , 1995, Advances in experimental medicine and biology.

[131]  S. Parthasarathy,et al.  Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. , 1991, The Journal of clinical investigation.

[132]  D. Steinberg,et al.  Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.